Supplementary Figure 1 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes

Supplementary Figure 1 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes

<p>Overall survival of ATM, BRCA2 mutant, and HRDother mPCs.</p>

Shranjeno v:

Bibliografske podrobnosti
Glavni avtor:	Justin Hwang (15925675) (author)
Drugi avtorji:	Xiaolei Shi (15925678) (author), Andrew Elliott (15925681) (author), Taylor E. Arnoff (14963396) (author), Julie McGrath (15078600) (author), Joanne Xiu (15051480) (author), Phillip Walker (15925684) (author), Hannah E. Bergom (15925687) (author), Abderrahman Day (15925690) (author), Shihab Ahmed (15925693) (author), Sydney Tape (15925696) (author), Allison Makovec (15925699) (author), Atef Ali (15925702) (author), Rami M. Shaker (15925705) (author), Eamon Toye (15925708) (author), Rachel Passow (15925711) (author), John R. Lozada (15925714) (author), Jinhua Wang (15925717) (author), Emil Lou (14957109) (author), Kent W. Mouw (15925720) (author), Benedito A. Carneiro (15925723) (author), Elisabeth I. Heath (15024674) (author), Rana R. McKay (15062884) (author), W. Michael Korn (15021032) (author), Chadi Nabhan (15051498) (author), Charles J. Ryan (15037635) (author), Emmanuel S. Antonarakis (14971443) (author)
Izdano:	2025
Teme:	Cancer Molecular and Cellular Biology Genome Biology Comparative transcriptomics Functional genomics
Oznake:	Označite Brez oznak, prvi označite!

Podobne knjige/članki

Supplementary Figure 2 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
od: Justin Hwang (15925675)
Izdano: (2025)

Supplementary Figure 3 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
od: Justin Hwang (15925675)
Izdano: (2025)

Supplementary Table 1 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
od: Justin Hwang (15925675)
Izdano: (2025)

Supplementary Table 2 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
od: Justin Hwang (15925675)
Izdano: (2025)

Supplementary Table 3 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
od: Justin Hwang (15925675)
Izdano: (2025)

Structural variants of <i>Fragaria vesca</i>
od: Minto Odagiri (22680003)
Izdano: (2025)

Gene expression data of <i>Fragaria vesca</i>
od: Minto Odagiri (22680003)
Izdano: (2025)

Processed snRNA-seq data from wild-type and <i>Pink1</i>-deficient mouse gut
od: Muhammad Junaid (14524523)
Izdano: (2025)

Supplementary fig 1 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
od: Jiwei Bai (15051797)
Izdano: (2025)

Supplementary fig 2 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
od: Jiwei Bai (15051797)
Izdano: (2025)

Supplementary fig 3 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
od: Jiwei Bai (15051797)
Izdano: (2025)

Supplementary fig 4 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
od: Jiwei Bai (15051797)
Izdano: (2025)

Supplementary fig 5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
od: Jiwei Bai (15051797)
Izdano: (2025)

Table S1-S5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
od: Jiwei Bai (15051797)
Izdano: (2025)

liverRegression code.
od: Amy Stephen (22684448)
Izdano: (2025)

Supplementary Table S2 from Clinical Relevance of <i>BRCA1</i> Promoter Methylation Testing in Patients with Ovarian Cancer
od: Félix Blanc-Durand (15049400)
Izdano: (2025)

scRNA-seq, Oligodendrocyte-Lineage Meta-Atlas
od: Nicholas Mikolajewicz (11242755)
Izdano: (2025)

Data file 1. Figure 1. Overview of <i>L. loa</i> specimen and genomic representation
od: Jeanne Arline Rajaonarivelo (17282572)
Izdano: (2025)

<b>Demographic History and </b><b>Natural Selection</b><b> Regimes Shape Divergent Genomic Architectures in Two Endangered Island Oaks</b>
od: Wenji Luo (4760160)
Izdano: (2025)

<i>K. pneumoniae</i> genomes represented in amr.watch as of 31 March 2025, filtered by the presence of the carbapenem resistance gene, <i>bla</i><sub>NDM-5</sub>.
od: Sophia David (4172902)
Izdano: (2025)

<b>Evolution of extensive neo-sex chromosomes and PAR shift in </b><b><i>Agapornis</i></b><b> lovebirds (</b><b>Supporting files, FISH raw data)</b>
od: Haoran Luo (16515177)
Izdano: (2025)

Supplementary Spreadsheet S1 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
od: Eileen M. Boyle (15015425)
Izdano: (2025)

Supplementary Spreadsheet S10 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
od: Eileen M. Boyle (15015425)
Izdano: (2025)

Supplementary Spreadsheet S11 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
od: Eileen M. Boyle (15015425)
Izdano: (2025)

Supplementary Spreadsheet S12 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
od: Eileen M. Boyle (15015425)
Izdano: (2025)

Supplementary Spreadsheet S2 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
od: Eileen M. Boyle (15015425)
Izdano: (2025)

Supplementary Spreadsheet S3 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
od: Eileen M. Boyle (15015425)
Izdano: (2025)

Supplementary Spreadsheet S4 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
od: Eileen M. Boyle (15015425)
Izdano: (2025)

Supplementary Spreadsheet S5 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
od: Eileen M. Boyle (15015425)
Izdano: (2025)

Supplementary Spreadsheet S6 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
od: Eileen M. Boyle (15015425)
Izdano: (2025)

Supplementary Spreadsheet S7 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
od: Eileen M. Boyle (15015425)
Izdano: (2025)

Supplementary Spreadsheet S8 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
od: Eileen M. Boyle (15015425)
Izdano: (2025)

Supplementary Spreadsheet S9 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
od: Eileen M. Boyle (15015425)
Izdano: (2025)

The interactive amr.watch application here shows an overview from 179,518 <i>E. coli</i> genomes available as of 31 March 2025.
od: Sophia David (4172902)
Izdano: (2025)

Table S1 from ENIGMA <i>CHEK2</i>gether Project: A Comprehensive Study Identifies Functionally Impaired <i>CHEK2</i> Germline Missense Variants Associated with Increased Breast Cancer Risk
od: Lenka Stolarova (16547259)
Izdano: (2025)

Table S2 from ENIGMA <i>CHEK2</i>gether Project: A Comprehensive Study Identifies Functionally Impaired <i>CHEK2</i> Germline Missense Variants Associated with Increased Breast Cancer Risk
od: Lenka Stolarova (16547259)
Izdano: (2025)

Table S3 from ENIGMA <i>CHEK2</i>gether Project: A Comprehensive Study Identifies Functionally Impaired <i>CHEK2</i> Germline Missense Variants Associated with Increased Breast Cancer Risk
od: Lenka Stolarova (16547259)
Izdano: (2025)

DeepEvo
od: Juntian Qi (22578974)
Izdano: (2025)

Table S2 from The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors
od: Elena Llano (14963220)
Izdano: (2025)

Table S3 from The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors
od: Elena Llano (14963220)
Izdano: (2025)

Cannot write session to /tmp/vufind_sessions/sess_c7ktbk3cgv32i6tufad8ca41e2